gilteritinib
astellas
['morpho trial', 'aml,(-streamline),(-seamless),(-kamloops),(-latamleaders)', 'leusm', 'aml,(-streamline),(-seamless),(-kamloops),(-dreamlike)', 'gilteritinib']
there was a clinical improvement of rfs among patients with flt3-itd mutant #aml and detectable mrd after hct in the phase 3 bmt-ctn 1506/morpho trial of #gilteritinib. #leusm #eha2023 
Oncology news and insights from leading researchers and cancer centers.